Frailty Consultant Services across Brent and Harrow
Central London Community Healthcare (CLCH) seeks to implement an integrated medical model for Urgent Community Response (UCR), Enhanced Care Home Teams (ECHT), Integrated Case Management (ICM) and Falls Services across Brent and Harrow.<br/><br/>This model aims to enhance operational efficiency, ensure cost-effective resource allocation, and improve patient safety and quality of care across frailty and falls pathways.<br/><br/>The new model consolidates multiple current contracting arrangements, into a single CLCH-procured Frailty Consultant Service, supported by a structured GP cross-cover model.<br/><br/>The provider of the Frailty Consultant Service will provide Consultant(s) that will be the clinically accountable clinician(s) for the integrated Brent and Harrow UCR, ECHT, ICM and Falls services, providing clinical leadership, medical oversight, and strategic direction to ensure consistent, high-quality community care.<br/><br/>Key Aims<br/>• Deliver 52-week consultant clinical accountability and governance across all frailty services.<br/>• Provide expert medical input to complex community cases, admission prevention, and safe discharge planning.<br/>• Lead and support multidisciplinary teams (MDTs) in Brent and Harrow.<br/>• Develop, implement and monitor clinical pathways and escalation processes.<br/>• Strengthen integration between community and acute care, social services and primary care partners.<br/>• Support quality improvement, audit, and staff development initiatives aligned with CLCH’s strategic priorities.<br/><br/>The contract will be for two years with the option to extend for a further one year.
Central London Community Healthcare NHS TrustLondonWAC-592329
NHS England are seeking specialist external support to deliver a financial improvement programme across AACC through two key approaches: large-scale package-level financial reviews and targeted system deep dives.
Please note the following general conditions:
• This RFI will help us to refine the requirements, future strategy and understand suppliers potential capabilities in the marketplace.
• Should a further competition be undertaken we reserve the right to only invite suppliers who have only initially responded to the RFI
• We reserve the right not to proceed with a further competition.
• Nothing shall constitute a commitment to ordering unless we undertake a further competition that results in the award of a Call-Off Contract.
• Any and all costs associated with the production of such a response either to a RFI or a further competition must be borne by the Supplier. We will not contribute in any way to meeting production costs of any response.
• Information contained within this document is confidential and must not be revealed to any third party without prior written consent from us.
• No down-selection of Potential Providers will take place as a consequence of any responses or interactions relating to this RFI.
• We expect that all responses to this RFI will be provided by Potential Providers in good faith to the best of their ability in the light of information available at the time of their response.
• No information provided by a Potential Provider in response to this RFI will be carried forward, used or acknowledged in any way for the purpose of evaluating the Potential Provider, in any subsequent formal procurement process.
HR&OD Procurement of psychometric tools and services for use in selection and development activities, including associated in-house training and development.
NLFT is seeking to procure an Ambient Voice Technology (AVT) solution as part of its digital transformation strategy. The aim is to reduce clinicians’ administrative burden and improve the timeliness and quality of clinical documentation across the Trust.
At this stage, NLFT is undertaking early market engagement to better understand the current capabilities, maturity, integration and delivery models available within the AVT market. This Request for Information (RFI) is intended to gather insights from suppliers to help shape the Trust’s requirements, approach to implementation, and overall procurement strategy.
More information and RFI document can be found here . https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a07Pz00001bHf7YIAS&searchStr=&sortStr=Recently+Published&page=1&filters=&County=
Provision of: Positron Emission Tomography – Computed Tomography (PET-CT) Services (all ages) and the Supply of Tracers
NHS England Specialised Commissioning (the "Contracting Authority”) is inviting suitably qualified and experienced suppliers to express an interest in providing Positron Emission Tomography – Computed Tomography (PET-CT) Services (all ages) and/or supplying the Tracers to providers of the Services, by responding to this opportunity. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Contracting Authority and is supporting the ITT.
PET-CT is a specialist diagnostic scan which is used extensively in cancer; it is also used in a relatively small number of other non-cancer specialties, such as neurology and infection and immunity. The scan itself involves the use of radioisotopes (or ‘tracers’) which are injected into the patient around an hour prior to the scan. Tracers can be grouped into those which are produced in cyclotron and hot cell facilities (‘standard tracers’), and those which typically need to be produced in radiopharmacy facilities that are co-located with scanners, due to radioactive half-life considerations (‘non-standard tracers’). Standard tracers account for >90% of PET-CT activity and almost all standard tracer scans involve FDG (a tracer).
The single procurement opportunity will comprise two lots:
Lot 1 - Scanning Services, including the optional supply of Gallium Non-Standard Tracers (NSTs) (the option will be procured by way of variant tenders as explained further below); and
Lot 2 – Supply of Standard Tracers (STs).
Each Lot will comprise of 12 identical Sub-Lots, enabling the pairing of Lot 1 and Lot 2 suppliers so that a complete PET-CT service is available to patients within those 12 Sub-Lot areas.
On completion of the procurement, there will be 12 scanning services, which will together equate to c.50% of the NHS PET-CT market in England. The opportunity also includes a variant bid element within Lot 1, which will allow bidders to put forward proposals to establish up to 6 gallium scanning services nationally, i.e., 1 per NHS England Region included within the procurement opportunity. This is to enable increased access for patients to gallium scans.
It is also proposed to future-proof the provision of amyloid scanning – this will only be activated within the Contracts in the event that approval is given for the use of disease modifying treatments for memory loss conditions and that those treatments require PET-CT amyloid scanning. This step has been taken to futureproof the Contracts for a potential, but not certain, service development.
Form of contracts:
The contracts to be entered into will be:
Lot 1 - Scanning Services: Contracts will be entered into on the form of the NHS Standard Contract 2026/27. Where gallium is to be supplied as part of a consortium, the Contracting Authority will mandate a form of 'sub-contract' for use between the scanning services provider and the gallium supplier.
Lot 2 - Standard Tracer Supply: Contracts will be entered into on the form of a bespoke supply of goods contract (as the NHS Standard Contract is not appropriate for a supply of goods contract). The form of contract will be mandated as a sub-contract between the scanning services provider in the relevant geography in Lot 1 and the standard tracer supplier in the corresponding geography in Lot 2. This model has been used previously to secure PET-CT provision.
Direct Agreements – The Contracting Authority will also enter into a direct agreement with the successful standard tracer suppliers (to ensure proper flow down across all contracts linked to the procurement opportunity).
Open procedure description:
This procurement will follow an Open Procedure. This will be a single stage procurement where Bidders are asked to submit a response to the PSQ and ITT on the same date. Only bidders that pass the PSQ will have their tender response evaluated. No additional steps will be used.
Following publication of this Tender Notice, bidders will be required to complete an EWA before receiving access to the Invitation to Tender (ITT). Completion of these will be a gateway requirement for access to the ITT, and bidders must submit their completed EWA within the timescales set out in this Tender Notice. Following confirmation of compliance, the ITT will be released simultaneously to all eligible bidders (see below) in early March 2026.
Indicative procurement timeline (which is subject to change at NHSE’s discretion):
• Tender Notice publication: 18/02/2026
• Access provided to EWA : 18/02/026
• Deadline for submission of EWA : 4/03/2026
• PSQ and ITT issued to all eligible bidders (see below): early March 2026
• Clarification question period deadline: mid-May 2026
• Final clarification question log issued: mid to late May 2026
• PSQ and ITT submission deadline: early June 2026
Eligible bidders are bidders who have received confirmation from NHSE that their submitted EWA has been counter-signed. Please allow approximately four (4) working days for the Contracting Authority to process your submission and confirm eligibility.
The Contracting Authority may consider allowing late submission of the EWA , however in no circumstances can bidders submit this documentation after 06/03/2026 at 12:0hrs. Bidders who are late to submit their EWA documents will be required to submit their PSQ and ITT responses on the same date as bidders who submit their EWA documents on time.
The PSQ will be assessed on a pass/fail basis covering legal, financial and technical requirements. Tenders from bidders that pass all PSQ criteria will then be evaluated. Bidders who fail the PSQ will be excluded and will not have their tenders evaluated.
A clarification process will operate during the PSQ and ITT period to enable bidders to seek clarification from the Contracting Authority.
Due diligence will be undertaken by the Contracting Authority prior to contract award to provide assurance that there are no material risks that could prevent contract signature i.e. if a Supplier bidding for the contract no longer meets the minimum standards required, and their Tender is rejected as a result, the Contracting Authority reserves the right to award the Contract to the next highest scoring Supplier.
Please note the Contracting Authority reserves the right at any stage of the procurement to abandon the competition and not award a contract. The Contracting Authority also reserves the right to make minor amendments to the procurement documentation (for example, to clarify or refine requirements), provided such changes are not substantial and do not distort competition. If amendments are made, the Contracting Authority will consider whether any corresponding tender deadlines require revision and will issue updated documentation or notices where appropriate.
NHS National Framework for Generics Pharmaceuticals Wave 16a
Offer reference number: CM/PHG/24/5714
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:
CM/PHG/24/5714/01 Oral (plus non-parenteral) products:
CESW/LSNE/NWLN: 1/02/2027 to 31/05/2030 (40 months)
CM/PHG/24/5714/02 Hospital only products:
DLN: 1/02/2027 to 31/01/2029 (24 months)
DNW: 1/02/2027 to 31/01/2029 (24 months)
CM/PHG/24/5714/03 Hospital only (housekeeping) products:
DCE/DSW: 1/02/2027 to 30/09/2027 (8 months)
DLS/DNE: 1/02/2027 to 31/05/2028 (16 months)
View 3-notice timelineLatest notice released 8 Jun 2026
NHS & HealthcareTender 3 notices
Building Safety Act Principle Designer Cath Lab 3 Refurbishment
The Authority has a requirement for Principal Designer Services to take the lead in planning, managing, monitoring and coordinating health and safety during the pre-construction (design and planning stage) and during construction stages for the Cath Lab 3 refurbishment.
The Authority wishes to engage with a principal designer to work closely with the project team, coordinating the work of others and ensuring significant and foreseeable risks are managed throughout the design process.
The Authority wishes to engage with a principal designer to work closely with the project team, coordinating the work of others and ensuring significant and foreseeable risks are managed throughout the design process.
The Project
Guys and St Thomas’ NHS Foundation Trust (GSTT) are to replacing their existing Cardiac Catheter Laboratory medical equipment and refurbishing the existing facilities within Cardiac Catheter Laboratory (Cath Lab No.3) at 4th floor level of the East Wing of the St Thomas’ Hospital site.
The Project has been designed and prepared to completion of RIBA 4.
Guy's and St Thomas' NHS Foundation TrustLondon9 Jun 2026WAC-597183
View 3-notice timelineLatest notice released 9 Jun 2026
NHS & HealthcareTender
Integrated Non-Custodial Services (INCS) in Coventry and Warwickshire (Lot 1) and West Mercia (Lot 2)
The Integrated Non‑Custodial Services(INCS) will be required to deliver a continuous, coordinated, and seamless model of non‑custodial criminal justice healthcare and support. The service will meet individuals identified health and wellbeing needs while addressing factors associated with offending behaviour, with a focus on early intervention, continuity of care, and improved outcomes across the criminal justice pathway.<br/><br/>The ITT documentation should be completed by 2pm on the 12 June 2026. The ITT reference is C443325.
This procurement seeks to commission three accredited Master’s-level paediatric audiology modules, delivered by higher education institutions and mapped to the British Academy of Audiology (BAA) Higher Training Scheme (HTS): Newborn Auditory Brainstem Response (ABR) Assessment; Visual Reinforcement Audiometry (VRA, 6 months+); and Paediatric Habilitation and Family-Centred Care.
Lot 1: Newborn Auditory Brainstem Response (ABR) Assessment (£138,000 max value)
One provider will be awarded under lot one.
Lot 2: Visual Reinforcement Audiometry (VRA) for infants aged 6 months and above (£229,500 max value)
Lot 3: Paediatric Habilitation and Family-Centred Care (£262,500 max value)
Up to two providers will be awarded under lots 2&3. Places will be split equally between the two supplier, if there is an uneven number of places the first ranked supplier will be given the extra place.
If only one supplier is awarded they will be awarded all the places under that lot.
Suppliers may bid for more than one lot.
This will be a three year contracts with optional 12 month extension.
Total funding available is £630,000 This will train up to 420 learners across all lots over the length of the contract. Price per learner per module is a maximum of £1500.
The deadline for submission of completed ITQ submissions is 12th June 2026 at 12:00pm (midday).
Late submissions will not be accepted therefore, please submit in good time prior to the deadline date and time. All communications should be made via the messaging function on the e-Tendering portal during the tender exercise.
The Contracting Authority requests that all communications are channelled through the e-portal system and not with the Contracting Authority itself other than as expressly permitted within this ITQ.
Further information relating to this project can be found at NHSE e-tendering portal at the link below. All clarification questions and submission bids must be received via this portal only. Registration is free of charge.
https://health-family-contract-search.secure.force.com/?SearchType=Projects
View 3-notice timelineLatest notice released 12 Jun 2026
NHS & HealthcareTender 2 notices
General Practice Assistant (GPA) Accredited Education Route
Provision of Level 4 accredited GPA training including learner support, mentorship guidance, portfolio assessment, accreditation, quality assurance, reporting, and collaborative working with regional Training Hubs.
The estimated value of the Contract(s) over a maximum 5 year term is the maximum expenditure that the Contracting Authority has budgeted for payment under the Contract(s). Including all extensions this is £13,749,255.00 (Exclusive of VAT).
The Awarded Contracts shall be payable based on the volume of activity with a maximum price per learner of £3,711.00 (Exclusive of VAT).
The initial contract term shall be 3 years with the potential for 2 years in Contract extension periods by election of the Contracting Authority, on such notice and for such periods as is specified by the Contract.
The Contracting Authority anticipates that it will enter into a contract with between 1 to 7 providers.
The deadline for submission of completed ITT submissions is 12th June 2026 at 12:0pm (midday).
Late submissions will not be accepted therefore, please submit in good time prior to the deadline date and time. All communications should be made via the messaging function on the e-Tendering portal during the tender exercise.
The Contracting Authority requests that all communications are channelled through the e-portal system and not with the Contracting Authority itself other than as expressly permitted within this ITT.
Further information relating to this project can be found at NHSE e-tendering portal at the link below. All clarification questions and submission bids must be received via this portal only. Registration is free of charge.
https://health-family-contract-search.secure.force.com/?SearchType=Projects
Procurement for the provision of professional services to conduct behavioural assessments.
Supplier Briefing call 28 May 2026 11:0 - 11:45 via Teams sign up - https://events.teams.microsoft.com/event/a5adabc1-06ba-49b3-a378-f8a71057fc8f@37c354b2-85b0-47f5-b222-07b48d774ee3
NHS Litigation AuthorityLondon18 Jun 2026WAC-597953
The project includes building works throughout 103 Denmark Hill, a building comprising of basement, ground, first and second floor, that requires refurbishment to bring it back into a condition that is fit for use as meeting rooms and office accommodation. The refurbishment works will address identified maintenance issues, improve internal spaces and upgrade building services to support the intended administrative use of the building
South London and Maudsley NHS Foundation Trust19 Jun 2026WAC-603048
NHS South East London Integrated Care Board intends to procure a Community Ear Wax Removal Service for residents across South East London.
The service is expected to provide a safe, accessible and person-centred ear wax removal service for adults who require clinical intervention for the management of impacted ear wax. The future service is intended to improve timely access to care, reduce variation across boroughs, support equitable access for underserved groups, and help reduce avoidable demand on primary and secondary care services.
The service is likely to include assessment, ear wax removal procedures, advice and guidance, onward referral where clinically appropriate, and support for people who may struggle to access traditional clinic-based provision, including consideration of domiciliary pathways.
The ICB is seeking a provider model that delivers high-quality care, responsive access, strong patient experience, and effective integration with wider audiology, ENT and primary care pathways. Further details regarding service requirements, contract duration and financial envelope will be included within the procurement documents issued at the next stage.
NHS South East London Integrated Care BoardLondon19 Jun 2026WAC-598800
NHS London Procurement Partnership (NHS LPP) (hosted by Guy’s & St Thomas’ NHS Foundation Trust) intends to undertake pre‑market engagement in advance of a planned procurement to establish a multi‑supplier framework agreement for the supply of in‑patient parenteral nutrition (PN) products and associated delivery/logistics services for NHS Trusts. The framework will support the safe and compliant supply of PN for patients with complex nutritional requirements across multiple settings.
The framework is intended to provide a compliant route to market for licensed PN products, ingredients/components, and unlicensed / aseptically prepared PN (including supplemented and named‑patient/bespoke products), alongside appropriate delivery models. Trusts remain responsible for awarding and managing call‑off contracts under the framework.
Purpose of this pre‑market engagement
This PME seeks supplier feedback to help refine:
1. the proposed scope, lotting and specifications (including feasibility, capacity, lead times, cold chain/logistics and resilience expectations);
2. the proposed commercial and pricing approach (including pricing structure and in‑term price review/indexation principles, where applicable);
3. assurance and quality requirements (including regulatory, QA and traceability expectations) and how these can be evidenced proportionately; and
4. practical considerations for call‑off operation (direct award parameters, further competition design, mobilisation and implementation support).
This procurement is subject to Cabinet Office Controls assurance (including NHS England / Cabinet Office spend controls approvals, as applicable). As a result, the Authority confirms that any element of the proposed procurement may change following controls assurance, including (but not limited to) scope, lotting, commercial model, timetable, evaluation approach and final procurement route/design. Nothing in this PME notice or any associated engagement activity constitutes a commitment by the Authority to proceed with the procurement on the basis described, nor does it form part of the procurement documents.
How suppliers can participate
Suppliers wishing to participate in this pre‑market engagement must first request access to the PME materials. Access will be controlled and will only be provided to organisations that can demonstrate they are genuine potential market participants.
To request access, suppliers must complete and return the PME Supplier Access Control Pack, comprising both of the following documents:
Document 1 – Supplier Registration and Access Form (including confirmation of the lots of interest and relevant capability); and
Document 2 – Confidentiality Undertaking
Suppliers must return the completed documents to the Authority using the contact details provided in the Access Control Pack. Incomplete or inaccurate forms may result in access being delayed or refused. Once the Authority has received and checked the completed Access Control Pack, participating suppliers will be provided with the relevant PME documents and a supplier questionnaire to complete. The PME materials must be used solely for the purpose of participating in this PME activity and must not be shared beyond named personnel on a strict need‑to‑know basis.
Participation in PME is voluntary and does not form part of any procurement process, does not constitute an invitation to tender, and will not confer any advantage in any future competition. In accordance with the Procurement Act 2023, the Authority will ensure that any relevant non‑confidential information obtained through pre‑market engagement which could otherwise give rise to an unfair advantage is made available to all bidders at tender stage.
Guy's and St Thomas' NHS Foundation TrustLondon19 Jun 2026WAC-598042